信息搜索
信息关键字：药
  

共有5246条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]

·以岭药业涨停三机构合计净卖出1.39亿元2022-4-14 17:52:11
·森萱医药董事长吴玉祥：公司没有转板意向2022-4-14 17:48:39
·普利制药放量大跌19.31%四机构合计卖出2.88亿元2022-4-14 17:48:02
·复盘85涨停股：九安医疗3板以岭药业反包皇台酒业6天4板2022-4-14 16:43:10
·诺诚健华科创板IPO过会拟募资40亿多半将用于新药研发2022-4-14 16:40:01
·王思聪发微博称证监会应严查以岭药业公司回怼：请指出具体问题2022-4-14 16:29:08
·王思聪微博称证监会应严查以岭药业公司回怼：请指出具体问题2022-4-14 16:25:33
·红日药业那屈肝素钙注射液获批上市2022-4-14 14:29:00
·公告“打架”？非经营性资金占用竟是工作人员失误所致，佛慈制药澄清后再收深交所关注函2022-4-14 13:30:20
·八大券商主题策略：回调即买入机会！重申看好新冠产业链三大逻辑力挺中药股2022-4-14 12:52:24
·亿帆医药2021年净利润2.8亿元同比降71%：市场推广费成为“吃”利润大户2022-4-14 12:15:05
·睿智医药24亿收购资产业绩变脸致首亏15亿出售益生元回血押宝新业务前途未卜2022-4-14 11:32:42
·热点公司简报〡奥翔药业：公司目前尚无新冠药物相关产品浙江鼎力：美反倾销举措利空公司美国市场2022-4-14 11:10:57
·中药板块异动拉升2022-4-14 10:05:17
·业绩大增股价冲高回落昭衍新药的高管们再减持387万股2022-4-14 9:57:39
·中药板块早盘走强2022-4-14 9:52:28
·罗欣药业业绩未达标触发补偿条款引入外企团队掌舵营销2022-4-14 8:52:09
·突发！日本新冠药物又生变故，或影响胎儿发育，龙头股盘中闪崩！日元也崩了，散户最受伤-财经2022-4-14 8:31:12
·普利制药2021年净利4.11亿同比增长0.84%发展各项产品推广2022-4-14 7:26:28
·康乐药业2021年净利1.12亿同比下滑16.7%研发费用同比上升2022-4-14 6:35:22

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]